You are here

Article Text

Article menu
Download PDFPDF
Diagnosis
BNP and amino terminal proBNP assays did not differ for detecting congestive heart failure in the emergency department

https://doi.org/10.1136/ebm.10.5.148

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Mueller T, Gegenhuber A, Poelz W, et al. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 2005;91:606–12.
    OpenUrlAbstract/FREE Full Text

    
 
 Q In emergency department (ED) patients with dyspnoea, how do B type natriuretic peptide (BNP) concentrations compare with amino terminal proBNP (NT-proBNP) concentrations for detecting congestive heart failure (CHF)?

    Clinical impact ratings Internal medicine ★★★★★★★ Emergency medicine ★★★★★☆☆ Cardiology ★★★★★★☆

    METHODS

    Embedded ImageDesign:

    blinded comparison of BNP and NT-proBNP concentrations with a comfirmatory diagnosis of CHF based on the Framingham criteria after reviewing patient medical records.

    Embedded ImageSetting:

    a hospital in Linz, Austria.

    Embedded ImagePatients:

    251 ED patients (mean age 73 y, 93% men) who had shortness of breath as the most prominent symptom. Patients with acute coronary syndromes were excluded.

    Embedded ImageDescription of tests:

    BNP and NT-proBNT concentrations in plasma were measured by the AxSYM BNP assay (Abbott Laboratories, Abbot Park, IL, USA) and the Elecsys NT-proBNP test (Roche Diagnositics), respectively.

    Embedded ImageDiagnostic standard:

    blinded …

    View Full Text